AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/220
IMMUNOPHENOTYPIC AND CYTOGENETIC FEATURES OF 10 PATIENTS WITH MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (FAB M0)
Authors: SASO R KULKARNI S TRELEAVEN J KILLICK S REGE K MEHTA J SINGHAL S MORILLA R ATRA A SWANSBURY GJ POWLES R CATOVSKY D
Citation: R. Saso et al., IMMUNOPHENOTYPIC AND CYTOGENETIC FEATURES OF 10 PATIENTS WITH MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (FAB M0), Blood, 90(10), 1997, pp. 3732-3732
BIPHENOTYPIC LEUKEMIA - 8 YEAR EXPERIENCE FROM THE ROYAL-MARSDEN-HOSPITAL
Authors: KILLICK S POWLES R KULKARNI S MATUTES E ATRA A ZOMAS A MELLER S HAMBLIN M SWANSBURY J HORTON C TRELEAVEN J CATOVSKY D
Citation: S. Killick et al., BIPHENOTYPIC LEUKEMIA - 8 YEAR EXPERIENCE FROM THE ROYAL-MARSDEN-HOSPITAL, Blood, 90(10), 1997, pp. 3832-3832
ERYTHROLEUKEMIA (AML M6) - 18 YEAR EXPERIENCE FROM THE ROYAL-MARSDEN-HOSPITAL
Authors: KILLICK S KULKARNI S POWLES R MATUTES E SASO R HAMBLIN M REGE K TRELEAVEN J MELLER S SWANSBURY J HORTON C CATOVSKY D
Citation: S. Killick et al., ERYTHROLEUKEMIA (AML M6) - 18 YEAR EXPERIENCE FROM THE ROYAL-MARSDEN-HOSPITAL, Blood, 90(10), 1997, pp. 3833-3833
ORAL IDARUBICIN AS SINGLE-AGENT THERAPY FOR PATIENTS WITH RELAPSED MULTIPLE-MYELOMA
Authors: SUMPTER K POWLES R RAJE N KULKARNI S RAMIAH V HILL M HORTON C MILAN S MEHTA J SINGHAL S RODRIGUEZ M MATEOS P LAUFENTE A TRELEAVEN J
Citation: K. Sumpter et al., ORAL IDARUBICIN AS SINGLE-AGENT THERAPY FOR PATIENTS WITH RELAPSED MULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 4144-4144
COMPARISON OF EQUAL DOSES OF LENOGRASTIM AND FILGRASTIM FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: KULKARNI S POWLES R TRELEAVEN J SINGHAL S RAJE N RAMIAH V GREGORY K DARK G MILLAR B SHEPHERD V NEVILLE F ANTRUM J HORTON C MILAN S MEHTA J
Citation: S. Kulkarni et al., COMPARISON OF EQUAL DOSES OF LENOGRASTIM AND FILGRASTIM FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Blood, 90(10), 1997, pp. 4226-4226
FEASIBILITY OF DONATING BOTH MARROW AND BLOOD-CELLS WITHIN A WEEK IN NORMAL DONORS
Authors: KULKARNI S POWLES R MEHTA J TRELEAVEN J SASO R LONG S ROWLAND A SINGHAL S
Citation: S. Kulkarni et al., FEASIBILITY OF DONATING BOTH MARROW AND BLOOD-CELLS WITHIN A WEEK IN NORMAL DONORS, Blood, 90(10), 1997, pp. 4227-4227
A NEW AUTOMATED APHERESIS SYSTEM FOR THE COBE SPECTRA CELL SEPARATOR UTILIZING THE PLATELET CHANNEL
Authors: MEHTA J POWLES R CABRAL S PROCTOR K MILLAR B SHEPHERD V KULKARNI S TRELEAVEN J SINGHAL S DEREYS S
Citation: J. Mehta et al., A NEW AUTOMATED APHERESIS SYSTEM FOR THE COBE SPECTRA CELL SEPARATOR UTILIZING THE PLATELET CHANNEL, Blood, 90(10), 1997, pp. 4240-4240
THE IMPLICATIONS OF CAVITY FORMATION ON CHEST-X-RAY IN INTENSIVE HEMATOLOGICAL PRACTICE
Authors: WILSON PC HILL ME POWLES R HORTON C KULKARNI S TRELEAVEN J
Citation: Pc. Wilson et al., THE IMPLICATIONS OF CAVITY FORMATION ON CHEST-X-RAY IN INTENSIVE HEMATOLOGICAL PRACTICE, Blood, 90(10), 1997, pp. 4442-4442
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA
Authors: KULKARNI S POWLES R TRELEAVEN J SINGHAL S SASTRY P RAJE N TAIT D MEHTA J
Citation: S. Kulkarni et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 4497-4497
BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MEHTA J POWLES R TRELEAVEN J KULKARNI S SINGHAL S SASO R HAMBLIN M REGE K CUNNINGHAM D KILLICK S TAIT D CATOVSKY D
Citation: J. Mehta et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 90(10), 1997, pp. 4503-4503
PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS IN ACUTE MYELOID-LEUKEMIA - IS RELAPSE THE ONLY EVENTUAL OUTCOME
Authors: MEHTA J POWLES R TRELEAVEN J KULKARNI S SINGHAL S
Citation: J. Mehta et al., PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS IN ACUTE MYELOID-LEUKEMIA - IS RELAPSE THE ONLY EVENTUAL OUTCOME, Blood, 90(10), 1997, pp. 4568-4568
PLASMA-CELL LEUKEMIA - OUTCOME FOLLOWING INFUSIONAL CHEMOTHERAPY AND AUTOGRAFTS
Authors: RAJE N POWLES R KULKARNI S RAMIAH V SUMPTER K HORTON C MEHTA J SINGHAL S TRELEAVEN J
Citation: N. Raje et al., PLASMA-CELL LEUKEMIA - OUTCOME FOLLOWING INFUSIONAL CHEMOTHERAPY AND AUTOGRAFTS, Blood, 90(10), 1997, pp. 4577-4577
A RANDOMIZED TRIAL OF SHORT-COURSE CONSOLIDATION CHEMOTHERAPY (MRC UKALL-X) FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA
Authors: RAMIAH V POWLES R SUMPTER K RAJE N KULKARNI S HILL M GREGORY K DARK G HORTON C MILAN S MEHTA J SINGHAL S FIELD M NEVILLE F ANTRUM J TRELEAVEN J
Citation: V. Ramiah et al., A RANDOMIZED TRIAL OF SHORT-COURSE CONSOLIDATION CHEMOTHERAPY (MRC UKALL-X) FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 4578-4578
SINGLE INSTITUTION REVIEW OF CASES OF AL AMYLOIDOSIS
Authors: SUMPTER K POWLES R RAJE N KULKARNI S RAMIAH V HILL M HORTON C MILAN S MEHTA J SINGHAL S RODRIGUEZ M MATEOS P LAUFENTE A TRELEAVEN J
Citation: K. Sumpter et al., SINGLE INSTITUTION REVIEW OF CASES OF AL AMYLOIDOSIS, Blood, 90(10), 1997, pp. 4583-4583
HEPATIC VENOOCCLUSIVE DISEASE (VOD) TREATED WITH RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA)
Authors: MATEOS P LAFUENTE A RODRIGUEZ M KULKARNI S MEHTA J SINGHAL S SASO R GREGORY K DARK G TAIT D TRELEAVEN J POWLES R
Citation: P. Mateos et al., HEPATIC VENOOCCLUSIVE DISEASE (VOD) TREATED WITH RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA), Blood, 90(10), 1997, pp. 964-964
INFLUENCE OF NUTRITIONAL-STATUS ON OUTCOME FOLLOWING TRANSPLANTATION FOR AML
Authors: HILL ME POWLES RL KULKARNI S HORTON C SUMPTER K MEHTA J SINGAL S TRELEAVEN J
Citation: Me. Hill et al., INFLUENCE OF NUTRITIONAL-STATUS ON OUTCOME FOLLOWING TRANSPLANTATION FOR AML, Blood, 90(10), 1997, pp. 975-975
TOTAL THERAPY OF ACUTE MYELOID-LEUKEMIA - 7-YEAR FOLLOW-UP
Authors: POWLES R TRELEAVEN J SINGHAL S KULKARNI S HORTON C TAIT D MEHTA J
Citation: R. Powles et al., TOTAL THERAPY OF ACUTE MYELOID-LEUKEMIA - 7-YEAR FOLLOW-UP, Blood, 90(10), 1997, pp. 1000-1000
SEQUENTIAL HIGH-DOSE THERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTPATIENTS - LONG-TERM FOLLOW-UP
Authors: SINGHAL S POWLES R TRELEAVEN J KULKARNI S HORTON C TAIT D MEHTA J
Citation: S. Singhal et al., SEQUENTIAL HIGH-DOSE THERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTPATIENTS - LONG-TERM FOLLOW-UP, Blood, 90(10), 1997, pp. 1033-1033
A DOUBLE-BLIND RANDOMIZED STUDY COMPARING THE EFFICACY OF ALLOGENEIC MARROW VERSUS BLOOD STEM-CELL TRANSPLANTATION
Authors: POWLES R KULKARNI S MEHTA J TRELEAVEN J MILLAR B SHEPHERD V TAIT D ANTRUM J NEVILLE F LONG S ROWLAND A SINGHAL S
Citation: R. Powles et al., A DOUBLE-BLIND RANDOMIZED STUDY COMPARING THE EFFICACY OF ALLOGENEIC MARROW VERSUS BLOOD STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 1118-1118
A RANDOMIZED TRIAL OF MAINTENANCE INTERFERON FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA - RESULTS 5 1 2 YEARS AFTER ACCRUAL OF THE LAST PATIENT/
Authors: POWLES R CUNNINGHAM D MALPAS J RAJE N MILAN S VINER C MONTES A HICKISH T NICOLSON M JOHNSON P TRELEAVEN J RAYMOND J GORE M
Citation: R. Powles et al., A RANDOMIZED TRIAL OF MAINTENANCE INTERFERON FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA - RESULTS 5 1 2 YEARS AFTER ACCRUAL OF THE LAST PATIENT/, Blood, 90(10), 1997, pp. 1588-1588
LONG-TERM FOLLOW-UP OF MYELOMA PATIENTS TREATED WITH 140 MG M(2) MELPHALAN WITHOUT AUTOLOGOUS TRANSPLANTATION/
Authors: POWLES R CUNNINGHAM D GORE M KULKARNI S SINGHAL S HORTON C MILAN S SASTRY P RAJE N TRELEAVEN J RAMIAH V MEHTA J
Citation: R. Powles et al., LONG-TERM FOLLOW-UP OF MYELOMA PATIENTS TREATED WITH 140 MG M(2) MELPHALAN WITHOUT AUTOLOGOUS TRANSPLANTATION/, Blood, 90(10), 1997, pp. 1589-1589
THALIDOMIDE IS VERY EFFECTIVE FOR CHRONIC GVHD BUT HAS NO ACTIVITY INACUTE GVHD
Authors: KULKARNI S POWLES R MEHTA J HORTON C TRELEAVEN J MELLER S ATRA A PINKERTON CR SINGHAL S
Citation: S. Kulkarni et al., THALIDOMIDE IS VERY EFFECTIVE FOR CHRONIC GVHD BUT HAS NO ACTIVITY INACUTE GVHD, Blood, 90(10), 1997, pp. 1673-1673
2ND CANCERS AFTER NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES - SINGLE-CENTER EXPERIENCE OF 883 PATIENTS
Authors: KULKARNI S POWLES R SINGHAL S TRELEAVEN J HORTON C MELLER S PINKERTON CR ATRA A TAIT D MEHTA J
Citation: S. Kulkarni et al., 2ND CANCERS AFTER NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES - SINGLE-CENTER EXPERIENCE OF 883 PATIENTS, Blood, 90(10), 1997, pp. 1674-1674
LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER AUTOGRAFTING FOR ACUTE-LEUKEMIA
Authors: TRELEAVEN J POWLES R SINGHAL S KULKARNI S TAIT D HORTON C MEHTA J
Citation: J. Treleaven et al., LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER AUTOGRAFTING FOR ACUTE-LEUKEMIA, Blood, 90(10), 1997, pp. 1691-1691
LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER ALLOGRAFTING FOR ACUTE-LEUKEMIA
Authors: MEHTA J POWLES R TRELEAVEN J KULKARNI S HORTON C TAIT D SINGHAL S
Citation: J. Mehta et al., LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER ALLOGRAFTING FOR ACUTE-LEUKEMIA, Blood, 90(10), 1997, pp. 1692-1692
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>